|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash on hand | ||||||||||||||
| Deferred Offering Costs | ||||||||||||||
| Prepaid expenses | ||||||||||||||
| Total current assets | ||||||||||||||
| Offering costs | ||||||||||||||
| Prepaid expenses, non-current | ||||||||||||||
| Cash and investments held in trust account | ||||||||||||||
| Total assets | ||||||||||||||
| Accrued offering costs and expenses | ||||||||||||||
| Promissory Note - related Party | ||||||||||||||
| Due to related party | ||||||||||||||
| Over-allotment liability | ||||||||||||||
| Total current liabilities | ||||||||||||||
| Deferred underwriting commisions | ||||||||||||||
| Warrant liability | ||||||||||||||
| Deferred liabilities | ||||||||||||||
| Deferred underwriting commissions | ||||||||||||||
| Total liabilities | ||||||||||||||
| Class A ordinary share subject to possible redemption, 1,738,127 and 21,562,401 shares at redemption value of $10.20 as of June 30, 2023 and December 31, 2022, respectively | ||||||||||||||
| Common Class A | ||||||||||||||
| Total class A ordinary share subject to possible redemption, 1,738,127 and 21,562,401 shares at redemption value of $10.20 as of June 30, 2023 and December 31, 2022, respectively | ||||||||||||||
| Class A ordinary share subject to possible redemption, 152,511 and 399,187 shares at redemption value of $12.23 and $11.69 as of June 30, 2025 and December 31, 2024, respectively | ||||||||||||||
| Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | ||||||||||||||
| Common stock value | ||||||||||||||
| Common Class A | ||||||||||||||
| Common Class B | ||||||||||||||
| Additional paid-in capital | ||||||||||||||
| Share Subscription Receivable | ||||||||||||||
| Accumulated deficit | ||||||||||||||
| Total Shareholders' Deficit | ||||||||||||||
| Total Liabilities, Redeemable Ordinary Shares and Shareholders' Deficit | ||||||||||||||
Loading...
